Zacks Investment Research on MSN19h
AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer IndicationAstraZeneca AZN announced that the FDA has approved its blockbuster drug, Imfinzi (durvalumab), for a bladder cancer ...
TipRanks on MSN4d
CG Oncology Advances in Bladder Cancer TherapeuticsCG Oncology, Inc. ( ($CGON) ) has released its Q4 earnings. Here is a breakdown of the information CG Oncology, Inc. presented to its investors.
Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback